Type 2 diabetes. Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Have type 2 diabetes and their diabetes has been diagnosed and confirmed by a doctor before registration Have diabetes for at least 6 months HbA1c level equal to or greater than 7 Be in the age range of 18 to 60 years old Be literate in reading and writing Have a phone at home Have a mobile phone personally or in the family in order to participate in the program Do not have disabling physical problems and diseases Are not pregnant and do not intend to become pregnant during the study period Do not suffer from known psychological diseases Do not suffer from serious diseases (such as liver failure, kidney failure, etc.) Willing to participate in the study and complete the informed consent form Do not currently participate in other research studies. Family member entry criteria: Be over 18 years old Do not have diabetes Be a First degree family member (wife, child, parent, sister or brother) Be literate in reading and writing Willing to participate in the study Can use a smartphone
Exclusion criteria
Exclusion criteria: Being hospitalized during the study for any reason Suffering from diabetic ketoacidosis or hyperglycemic hyperosmolar Nonketotic syndrome Suffering from serious diseases such as advanced form of cardiovascular diseases, uncontrolled high blood pressure, psychological disorders, severe vision disorders, psychiatry diseases or suffering from physical or mental problems preventing participation in the research Unwillingness of the patient or family member to participate or continue cooperation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication compliance score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Morisky Medication Adherence Scale.;Physical activity score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: International Physical Activity Questionnaire (IPAQ ).;Self-Efficacy Scale. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Diabetes Management Self-Efficacy Scale(DMSES).;Self-care behaviors score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Summary of Diabetes Self Care Activities (SDSCA).;Perceived family social support score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Diabetes Specific Family Support Scale.;Self-regulation score in treatment. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Treatment Self-Regulation Questionnaire (TSRQ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Blood sample test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences